Blood Cancer News and Research

RSS

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient's own tumor cells may prevent the incurable blood cancer mantle cell lymphoma (MCL) from returning after treatment.

22 Jun 2020

Study takes new treatment approach for blood cancer

In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific protein (alpha5beta1 integrin) to decrease the number of large bone marrow cells (megakaryocytes) in an experimental model.

21 Jun 2020

Researchers discover new and improved way to treat poor-prognosis blood cancer

Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukemia or AML.

21 Jun 2020

Drama-based resources help Kingston University nursing students to cope with coronavirus pandemic

A set of drama-based resources to help Kingston University, London nursing students working during the Covid-19 pandemic have been put together through a collaboration with world-leading performing arts school Guildhall School of Music & Drama, London.

21 Jun 2020

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Now, in a new study published on the preprint server, bioRxiv researchers in the U.S. investigated a soluble version of ACE2 for SARS-CoV-2 viral neutralization activity.

17 Jun 2020

Researchers confirm new therapeutic target for myelodysplastic syndrome

A research group from Kumamoto University, Japan analyzed the pathophysiology of myelodysplastic syndrome (MDS), a blood cancer that presents often in the elderly, and found the presence of the transcription factor RUNX3, thereby revealing a cancer growth function for what had been considered a tumor suppressor.

8 Jun 2020

Researchers discover key gene essential for survival of leukemia stem cells

Acute myeloid leukemia (AML) is one of the most common forms of blood cancer among adults and is associated with a low survival rate, and leads to the inhibition of normal blood formation.

3 Jun 2020

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Acute myeloid leukemia (AML), an aggressive blood cancer, is one of the most lethal cancers. More than 19,000 new cases are diagnosed a year, and more than 11,000 people a year die from it, according to the American Cancer Society.

3 Jun 2020

Study investigates outcome of COVID-19 infection in blood cancer patients

One of the first studies to investigate the outcome of COVID-19 infection in patients with blood cancer has been conducted by clinical researchers from Queen Mary University of London and Barts Health NHS Trust.

2 Jun 2020

Researchers test new treatment protocol for lymphoma

Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes.

29 May 2020

New follow-up care models could benefit thousands of cancer survivors

Thousands of cancer survivors could benefit from a new model of shared follow-up care delivered by specialist cancer care nurses, GPs, and cancer specialists incorporating telehealth sessions being implemented under a five-year $1.5 million NHMRC Investigator Grant.

22 May 2020

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. T

20 May 2020

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Researchers from SWOG, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health, will make 31 presentations as part of the ASCO20 Virtual Scientific Program, the online annual meeting of the American Society of Clinical Oncology (ASCO), which runs May 29-31.

19 May 2020

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

Some people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient's immune cells are eliminated during these transplantations.

14 May 2020

Study shows no association between prices and clinical benefit of cancer drugs

Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit.

2 May 2020

Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

A study of nearly 10,000 women with no cancer history found that a multi-cancer blood test successfully detected some cancers.

28 Apr 2020

Researchers discover physiological mechanisms underlying pediatric B-ALL

B-cell acute lymphoblastic leukemia (B-ALL) is characterized by the accumulation of abnormal immature B-cell precursors in the bone marrow and is the most common pediatric cancer.

23 Apr 2020

Cancer-causing mutation also promotes inflammation

Analyses of cell signals provide insight into the origin of severe inflammatory symptoms that appear in various types of blood cancer and point to possible therapeutic approaches: In around one-fourth of patients suffering from juvenile myelomonocytic leukemia, there is evidence of mutations in the so-called KRAS gene in the leukemia cells.

8 Apr 2020

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers.

5 Apr 2020

New blood test detects more than 50 types of cancer, including at early, more treatable stages

Researchers have developed a simple blood test that can detect over 50 types of cancer, often before signs or symptoms.

31 Mar 2020

Blood Cancer News and Research

Tumor cell–based vaccine may prevent relapse of mantle cell lymphoma

Study takes new treatment approach for blood cancer

Researchers discover new and improved way to treat poor-prognosis blood cancer

Drama-based resources help Kingston University nursing students to cope with coronavirus pandemic

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Researchers confirm new therapeutic target for myelodysplastic syndrome

Researchers discover key gene essential for survival of leukemia stem cells

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Study investigates outcome of COVID-19 infection in blood cancer patients

Researchers test new treatment protocol for lymphoma

New follow-up care models could benefit thousands of cancer survivors

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

Study shows no association between prices and clinical benefit of cancer drugs

Study of nearly 10,000 women explores feasibility and safety of multi-cancer blood test

Researchers discover physiological mechanisms underlying pediatric B-ALL

Cancer-causing mutation also promotes inflammation

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

New blood test detects more than 50 types of cancer, including at early, more treatable stages

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News